Last reviewed · How we verify
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
1 Phase 3
1 Phase 2
1 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Cabotegravir LA + Rilpivirine LA | Cabotegravir LA + Rilpivirine LA | marketed | Antiretroviral combination (INSTI + NNRTI) | HIV integrase and HIV reverse transcriptase | Infectious Disease / Virology | |
| Hipec with Cisplatin | Hipec with Cisplatin | phase 3 | Regional chemotherapy / Intraperitoneal chemotherapy | DNA (cisplatin acts as a platinum-based alkylating agent) | Oncology |
Therapeutic area mix
- Cardiovascular · 1
- Infectious Disease / Virology · 1
- Oncology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Dong-A ST Co., Ltd. · 1 shared drug class
- Generic (originally Searle/Pfizer) · 1 shared drug class
- Shanghai 10th People's Hospital · 1 shared drug class
- University Paris 7 - Denis Diderot · 1 shared drug class
- West China Hospital · 1 shared drug class
- Wolfson Medical Center · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia:
- Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia pipeline updates — RSS
- Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia pipeline updates — Atom
- Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/fundacion-para-la-formacion-e-investigacion-sanitarias-de-la-region-de-murcia. Accessed 2026-05-17.